News | February 11, 2023
Dishman Carbogen Amcis Q3 FY23 revenue up 14%
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
During the quarter, foreign exchange fluctuations had an impact of Rs. 4.56 crore Q3 FY23 Profit After Tax after considering exchange rate fluctuations stood at Rs. 8.2 crore
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Subscribe To Our Newsletter & Stay Updated
